❓Are genetic testing startups a goldmine or gamble?
The genetic testing industry has seen both triumphs and setbacks. 23andMe, once a high-flyer, faces layoffs and declining market value. Yet others, like prenatal-focused Natera, thrive with multibillion-dollar valuations. Startups like BillionToOne and Genome Medical are raising hefty funds, while niches like pet DNA testing lose steam.
Despite past bubbles, the $10B genetic testing market is predicted to double by 2033, hinting at massive growth opportunities, but not without risks.
❓Are genetic testing startups a goldmine or gamble?
The genetic testing industry has seen both triumphs and setbacks. 23andMe, once a high-flyer, faces layoffs and declining market value. Yet others, like prenatal-focused Natera, thrive with multibillion-dollar valuations. Startups like BillionToOne and Genome Medical are raising hefty funds, while niches like pet DNA testing lose steam.
Despite past bubbles, the $10B genetic testing market is predicted to double by 2033, hinting at massive growth opportunities, but not without risks.
False news often spreads via public groups, or chats, with potentially fatal effects. "Markets were cheering this economic recovery and return to strong economic growth, but the cheers will turn to tears if the inflation outbreak pushes businesses and consumers to the brink of recession," he added. Oleksandra Matviichuk, a Kyiv-based lawyer and head of the Center for Civil Liberties, called Durov’s position "very weak," and urged concrete improvements. So, uh, whenever I hear about Telegram, it’s always in relation to something bad. What gives? The picture was mixed overseas. Hong Kong’s Hang Seng Index fell 1.6%, under pressure from U.S. regulatory scrutiny on New York-listed Chinese companies. Stocks were more buoyant in Europe, where Frankfurt’s DAX surged 1.4%.
from tr
